1.
Dickerson F, Jones-Brando L, Ford G, et al. Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus. Schizophr Bull. 2019;45(5):1112-1119. doi:10.1093/schbul/sby164.
1.
Sadler JBA, Wenzel DM, Strohacker LK, et al. A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc Natl Acad Sci U S A. 2018;115(38):E8900-E8908. doi:10.1073/pnas.1805504115.
1.
Naj AC, Lin H, Vardarajan BN, et al. Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer’s disease sequencing project. Genomics. 2019;111(4):808-818. doi:10.1016/j.ygeno.2018.05.004.
1.
Nash A, Sewell T, Farrer RA, et al. MARDy: Mycology Antifungal Resistance Database. Bioinformatics. 2018;34(18):3233-3234. doi:10.1093/bioinformatics/bty321.
1.
Winkler EA, Yue JK, Ferguson AR, et al. COMT Val(158)Met polymorphism is associated with post-traumatic stress disorder and functional outcome following mild traumatic brain injury. J Clin Neurosci. 2017;35:109-116. doi:10.1016/j.jocn.2016.09.017.
1.
Chheda H, Palta P, Pirinen M, et al. Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom. Eur J Hum Genet. 2017;25(4):477-484. doi:10.1038/ejhg.2016.205.
1.
Schneider VA, Graves-Lindsay T, Howe K, et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 2017;27(5):849-864. doi:10.1101/gr.213611.116.
1.
Yu L, Lutz MW, Farfel JM, et al. Neuropathologic features of TOMM40 ’523 variant on late-life cognitive decline. Alzheimers Dement. 2017;13(12):1380-1388. doi:10.1016/j.jalz.2017.05.002.
1.
Mohanan V, Nakata T, Desch N, et al. is a colitis risk gene that regulates stability of epithelial adherens junctions. Science. 2018;359(6380):1161-1166. doi:10.1126/science.aan0814.
1.
Scally SW, Law S-C, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017;76(11):1915-1923. doi:10.1136/annrheumdis-2017-211300.